Genomics-based identification of a potential causal role for acylcarnitine metabolism in depression-Reference-Cited by-同舟云学术

Genomics-based identification of a potential causal role for acylcarnitine metabolism in depression

Published:2022-06 Issue: Volume:307 Page:254-263
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Milaneschi Yuri,Arnold Matthias,Kastenmüller Gabi,Dehkordi Siamak Mahmoudian,Krishnan Ranga R.,Dunlop Boadie W.,Rush A. John,Penninx Brenda W.J.H.,Kaddurah-Daouk Rima

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference58 articles.

1. Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypes;Ahmed;J. Affect. Disord.,2020

2. Elevated medium-chain acylcarnitines are associated with gestational diabetes mellitus and early progression to type 2 diabetes and induce pancreatic β-cell dysfunction;Batchuluun;Diabetes,2018

3. Epigenetics and energetics in ventral hippocampus mediate rapid antidepressant action: implications for treatment resistance;Bigio;Proc. Natl. Acad. Sci. U. S. A.,2016

4. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator;Bowden;Genet. Epidemiol.,2016

5. A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization;Bowden;Stat. Med.,2017

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohort;2024-08-11

2. The metabolome-wide signature of major depressive disorder;Molecular Psychiatry;2024-06-07

3. Abnormal energy metabolism, oxidative stress, and polyunsaturated fatty acid metabolism in depressed adolescents associated with childhood maltreatment: A targeted metabolite analysis;Psychiatry Research;2024-05

4. Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohort;2024-02-15

5. Metabolomic biomarkers for (R, S)‐ketamine and (S)‐ketamine in treatment‐resistant depression and healthy controls: A systematic review;Bipolar Disorders;2024-02-07